| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cadherin binding | 2.17e-04 | 339 | 51 | 6 | GO:0045296 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | TUBGCP6 CALD1 TRAF3IP1 SPTBN2 NUMA1 AFDN STMND1 DBN1 CCDC181 EPB41 | 3.97e-04 | 1099 | 51 | 10 | GO:0008092 |
| GeneOntologyMolecularFunction | microtubule minus-end binding | 6.57e-04 | 15 | 51 | 2 | GO:0051011 | |
| GeneOntologyBiologicalProcess | RNA splicing | DHX15 CWF19L2 RBM25 AKAP17A UPF3A SREK1 SNRNP70 RSRC1 CLASRP | 3.42e-06 | 502 | 51 | 9 | GO:0008380 |
| GeneOntologyBiologicalProcess | mRNA processing | DHX15 CWF19L2 RBM25 AKAP17A UPF3A SREK1 SNRNP70 RSRC1 CLASRP | 7.27e-06 | 551 | 51 | 9 | GO:0006397 |
| GeneOntologyBiologicalProcess | microtubule-based process | TUBGCP6 TRAF3IP1 INCENP INTS13 NUMA1 CFAP45 DYNC2I1 STMND1 CFAP44 HYDIN PHLDB2 | 4.41e-05 | 1058 | 51 | 11 | GO:0007017 |
| GeneOntologyBiologicalProcess | negative regulation of protein refolding | 5.97e-05 | 5 | 51 | 2 | GO:0061084 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | TUBGCP6 TRAF3IP1 INCENP INTS13 NUMA1 STMND1 CFAP44 HYDIN PHLDB2 | 5.98e-05 | 720 | 51 | 9 | GO:0000226 |
| GeneOntologyBiologicalProcess | mRNA metabolic process | DHX15 CWF19L2 RBM25 AKAP17A CTIF UPF3A SREK1 SNRNP70 RSRC1 CLASRP | 6.98e-05 | 917 | 51 | 10 | GO:0016071 |
| GeneOntologyBiologicalProcess | regulation of protein refolding | 8.93e-05 | 6 | 51 | 2 | GO:0061083 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to cell cortex | 8.93e-05 | 6 | 51 | 2 | GO:1904778 | |
| GeneOntologyBiologicalProcess | negative regulation of protein folding | 1.25e-04 | 7 | 51 | 2 | GO:1903333 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to cell cortex | 2.13e-04 | 9 | 51 | 2 | GO:1904776 | |
| GeneOntologyBiologicalProcess | mRNA splicing, via spliceosome | 2.44e-04 | 358 | 51 | 6 | GO:0000398 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 2.44e-04 | 358 | 51 | 6 | GO:0000377 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions | 2.59e-04 | 362 | 51 | 6 | GO:0000375 | |
| GeneOntologyBiologicalProcess | mitotic spindle elongation | 3.89e-04 | 12 | 51 | 2 | GO:0000022 | |
| GeneOntologyBiologicalProcess | protein localization to cell cortex | 3.89e-04 | 12 | 51 | 2 | GO:0072697 | |
| GeneOntologyBiologicalProcess | spindle elongation | 5.35e-04 | 14 | 51 | 2 | GO:0051231 | |
| GeneOntologyBiologicalProcess | regulation of protein folding | 5.35e-04 | 14 | 51 | 2 | GO:1903332 | |
| GeneOntologyBiologicalProcess | regulation of metaphase plate congression | 6.17e-04 | 15 | 51 | 2 | GO:0090235 | |
| GeneOntologyBiologicalProcess | regulation of microtubule-based process | 7.70e-04 | 293 | 51 | 5 | GO:0032886 | |
| GeneOntologyCellularComponent | nuclear body | DHX15 RBM25 AKAP17A INCENP INTS13 GRK5 AFDN SREK1 RERE ASCC3 SNRNP70 EPB41 RSRC1 | 1.34e-07 | 903 | 50 | 13 | GO:0016604 |
| GeneOntologyCellularComponent | nuclear speck | 7.34e-07 | 431 | 50 | 9 | GO:0016607 | |
| GeneOntologyCellularComponent | cortical cytoskeleton | 1.40e-05 | 129 | 50 | 5 | GO:0030863 | |
| GeneOntologyCellularComponent | spliceosomal complex | 1.60e-04 | 215 | 50 | 5 | GO:0005681 | |
| GeneOntologyCellularComponent | spectrin-associated cytoskeleton | 2.00e-04 | 9 | 50 | 2 | GO:0014731 | |
| GeneOntologyCellularComponent | cell cortex | 2.47e-04 | 371 | 50 | 6 | GO:0005938 | |
| GeneOntologyCellularComponent | post-mRNA release spliceosomal complex | 3.64e-04 | 12 | 50 | 2 | GO:0071014 | |
| GeneOntologyCellularComponent | spindle | 8.70e-04 | 471 | 50 | 6 | GO:0005819 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | 1.22e-03 | 899 | 50 | 8 | GO:0099513 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | DHX15 CWF19L2 AKAP17A INTS13 SMARCA2 UPF3A SREK1 RERE ASCC3 SNRNP70 | 1.36e-03 | 1377 | 50 | 10 | GO:0140513 |
| GeneOntologyCellularComponent | cortical actin cytoskeleton | 1.44e-03 | 93 | 50 | 3 | GO:0030864 | |
| GeneOntologyCellularComponent | spindle pole | 1.45e-03 | 205 | 50 | 4 | GO:0000922 | |
| GeneOntologyCellularComponent | microtubule | 1.64e-03 | 533 | 50 | 6 | GO:0005874 | |
| GeneOntologyCellularComponent | cytoplasmic region | 1.65e-03 | 360 | 50 | 5 | GO:0099568 | |
| GeneOntologyCellularComponent | postsynaptic cytoskeleton | 1.76e-03 | 26 | 50 | 2 | GO:0099571 | |
| GeneOntologyCellularComponent | excitatory synapse | 2.15e-03 | 107 | 50 | 3 | GO:0060076 | |
| Domain | - | 4.79e-04 | 244 | 50 | 5 | 3.30.70.330 | |
| Domain | UBX | 5.38e-04 | 13 | 50 | 2 | PS50033 | |
| Domain | UBX | 5.38e-04 | 13 | 50 | 2 | PF00789 | |
| Domain | UBX_dom | 5.38e-04 | 13 | 50 | 2 | IPR001012 | |
| Domain | Nucleotide-bd_a/b_plait | 6.17e-04 | 258 | 50 | 5 | IPR012677 | |
| Domain | Ubiquitin-rel_dom | 1.47e-03 | 184 | 50 | 4 | IPR029071 | |
| Domain | Helicase_C | 2.95e-03 | 107 | 50 | 3 | PF00271 | |
| Domain | HELICc | 2.95e-03 | 107 | 50 | 3 | SM00490 | |
| Domain | Helicase_C | 3.03e-03 | 108 | 50 | 3 | IPR001650 | |
| Domain | HELICASE_CTER | 3.10e-03 | 109 | 50 | 3 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 3.10e-03 | 109 | 50 | 3 | PS51192 | |
| Domain | DEXDc | 3.10e-03 | 109 | 50 | 3 | SM00487 | |
| Domain | Helicase_ATP-bd | 3.19e-03 | 110 | 50 | 3 | IPR014001 | |
| Domain | RRM | 3.31e-03 | 230 | 50 | 4 | PS50102 | |
| Domain | - | 7.28e-03 | 148 | 50 | 3 | 2.60.40.150 | |
| Domain | C2_dom | 9.63e-03 | 164 | 50 | 3 | IPR000008 | |
| Domain | AGC-kinase_C | 9.86e-03 | 56 | 50 | 2 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 9.86e-03 | 56 | 50 | 2 | PS51285 | |
| Domain | S_TK_X | 9.86e-03 | 56 | 50 | 2 | SM00133 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | DHX15 CWF19L2 ZNF609 RBM25 CALD1 INCENP BCORL1 NUMA1 KRI1 AFDN LRRC59 SREK1 DBN1 SNRNP70 EPB41 | 4.26e-12 | 954 | 51 | 15 | 36373674 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | TUBGCP6 RBM25 NUMA1 RNF20 SMARCA2 AFDN PKN1 RERE DBN1 PHLDB2 CLASRP | 1.31e-08 | 774 | 51 | 11 | 15302935 |
| Pubmed | DHX15 RBM25 INCENP SPTBN2 NUMA1 SMARCA2 KRI1 AFDN ASCC3 SNRNP70 | 3.25e-08 | 653 | 51 | 10 | 22586326 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 3.37e-08 | 220 | 51 | 7 | 35785414 | |
| Pubmed | Quantitative Proteomics Links the LRRC59 Interactome to mRNA Translation on the ER Membrane. | 7.21e-08 | 375 | 51 | 8 | 32788342 | |
| Pubmed | DHX15 RBM25 SPTBN2 KRI1 LRRC59 SREK1 DBN1 SNRNP70 RSRC1 CLASRP | 7.38e-08 | 713 | 51 | 10 | 29802200 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | DHX15 RBM25 FAF2 INCENP NUMA1 RNF20 KRI1 AFDN LRRC59 SREK1 DBN1 SNRNP70 ST13 | 9.67e-08 | 1425 | 51 | 13 | 30948266 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | DHX15 LSR RBM25 CALD1 SPTBN2 NUMA1 AFDN LRRC59 ASCC3 SNRNP70 PHLDB2 | 2.21e-07 | 1024 | 51 | 11 | 24711643 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | DHX15 ZNF609 RBM25 INTS13 BCORL1 NUMA1 RNF20 LRRC59 SNRNP70 SPTY2D1 RSRC1 CLASRP | 2.77e-07 | 1294 | 51 | 12 | 30804502 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | DHX15 RBM25 AKAP17A NUMA1 SMARCA2 KRI1 LRRC59 SREK1 ASCC3 SNRNP70 ST13 RSRC1 | 3.37e-07 | 1318 | 51 | 12 | 30463901 |
| Pubmed | 3.82e-07 | 467 | 51 | 8 | 30194290 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | DHX15 CWF19L2 RBM25 AKAP17A SPTBN2 CFAP45 LRRC59 UPF3A SREK1 DBN1 SNRNP70 | 3.83e-07 | 1082 | 51 | 11 | 38697112 |
| Pubmed | TUBGCP6 ZNF609 RBM25 AKAP17A INTS13 SMARCA2 SREK1 RERE USP54 ASCC3 PHLDB2 | 5.19e-07 | 1116 | 51 | 11 | 31753913 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | DHX15 TUBGCP6 ZNF609 CALD1 TRAF3IP1 INCENP SYTL4 NUMA1 SMARCA2 DYNC2I1 RSRC1 | 7.27e-07 | 1155 | 51 | 11 | 20360068 |
| Pubmed | ZNF609 RBM25 BCORL1 NUMA1 SMARCA2 KRI1 LRRC59 RERE USP54 DBN1 SNRNP70 RSRC1 | 7.93e-07 | 1429 | 51 | 12 | 35140242 | |
| Pubmed | TUBGCP6 LSR UBXN4 FAF2 SPTBN2 GKAP1 KRI1 LRRC59 SREK1 ASCC3 CSPP1 ST13 | 1.20e-06 | 1487 | 51 | 12 | 33957083 | |
| Pubmed | 1.28e-06 | 549 | 51 | 8 | 38280479 | ||
| Pubmed | 1.44e-06 | 131 | 51 | 5 | 34551306 | ||
| Pubmed | 1.55e-06 | 244 | 51 | 6 | 29884807 | ||
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | 1.59e-06 | 565 | 51 | 8 | 25468996 | |
| Pubmed | 1.74e-06 | 777 | 51 | 9 | 35844135 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 20109190 | ||
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 2.64e-06 | 605 | 51 | 8 | 28977666 | |
| Pubmed | 3.52e-06 | 847 | 51 | 9 | 35850772 | ||
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | 3.52e-06 | 847 | 51 | 9 | 35235311 | |
| Pubmed | 3.60e-06 | 441 | 51 | 7 | 31239290 | ||
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | DHX15 UBXN4 FAF2 CALD1 SMARCA2 AFDN LRRC59 SREK1 ST13 EPB41 PHLDB2 | 3.72e-06 | 1367 | 51 | 11 | 32687490 |
| Pubmed | DHX15 RBM25 AKAP17A SPTBN2 NUMA1 KRI1 LRRC59 ASCC3 SNRNP70 SPTY2D1 RSRC1 | 3.83e-06 | 1371 | 51 | 11 | 36244648 | |
| Pubmed | 3.87e-06 | 446 | 51 | 7 | 24255178 | ||
| Pubmed | 4.73e-06 | 655 | 51 | 8 | 35819319 | ||
| Pubmed | 5.61e-06 | 472 | 51 | 7 | 38943005 | ||
| Pubmed | NuMA interacts with phosphoinositides and links the mitotic spindle with the plasma membrane. | 6.32e-06 | 3 | 51 | 2 | 24996901 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 12239178 | ||
| Pubmed | NuMA localization, stability, and function in spindle orientation involve 4.1 and Cdk1 interactions. | 6.32e-06 | 3 | 51 | 2 | 24109598 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 21728385 | ||
| Pubmed | Drebrin preserves endothelial integrity by stabilizing nectin at adherens junctions. | 6.32e-06 | 3 | 51 | 2 | 23750010 | |
| Pubmed | 8.34e-06 | 708 | 51 | 8 | 39231216 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | 8.78e-06 | 949 | 51 | 9 | 36574265 | |
| Pubmed | LSR UBXN4 AKAP17A INTS13 SMARCA2 AFDN SREK1 ASCC3 SPTY2D1 EPB41 RSRC1 | 8.81e-06 | 1497 | 51 | 11 | 31527615 | |
| Pubmed | 8.81e-06 | 506 | 51 | 7 | 30890647 | ||
| Pubmed | NudCL2 regulates cell migration by stabilizing both myosin-9 and LIS1 with Hsp90. | 9.23e-06 | 333 | 51 | 6 | 32665550 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | 9.81e-06 | 724 | 51 | 8 | 36232890 | |
| Pubmed | 1.04e-05 | 340 | 51 | 6 | 29478914 | ||
| Pubmed | DHX15 ZNF609 RBM25 NUMA1 SMARCA2 LRRC59 UPF3A ASCC3 SNRNP70 PHLDB2 | 1.13e-05 | 1247 | 51 | 10 | 27684187 | |
| Pubmed | 1.19e-05 | 202 | 51 | 5 | 24639526 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | DHX15 RBM25 INCENP SPTBN2 NUMA1 KRI1 LRRC59 DBN1 ASCC3 PHLDB2 | 1.22e-05 | 1257 | 51 | 10 | 36526897 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | 1.22e-05 | 989 | 51 | 9 | 36424410 | |
| Pubmed | A nonerythroid isoform of protein 4.1R interacts with the nuclear mitotic apparatus (NuMA) protein. | 1.26e-05 | 4 | 51 | 2 | 10189366 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | LSR RBM25 FAF2 AKAP17A CCDC82 AFDN LRRC59 SREK1 SNRNP70 EPB41 | 1.46e-05 | 1284 | 51 | 10 | 17353931 |
| Pubmed | 1.61e-05 | 215 | 51 | 5 | 35973513 | ||
| Pubmed | 1.69e-05 | 104 | 51 | 4 | 31365120 | ||
| Pubmed | Identification of an FMNL2 Interactome by Quantitative Mass Spectrometry. | 1.82e-05 | 106 | 51 | 4 | 38891874 | |
| Pubmed | 2.10e-05 | 5 | 51 | 2 | 34406391 | ||
| Pubmed | 2.41e-05 | 234 | 51 | 5 | 36243803 | ||
| Pubmed | 2.67e-05 | 239 | 51 | 5 | 26641092 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | 3.17e-05 | 853 | 51 | 8 | 28718761 | |
| Pubmed | DHX15 FAF2 CALD1 SPTBN2 NUMA1 KRI1 LRRC59 ASCC3 SNRNP70 ST13 | 3.89e-05 | 1440 | 51 | 10 | 30833792 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | 3.96e-05 | 1149 | 51 | 9 | 35446349 | |
| Pubmed | 4.19e-05 | 131 | 51 | 4 | 28031328 | ||
| Pubmed | Cortical dynein and asymmetric membrane elongation coordinately position the spindle in anaphase. | 4.41e-05 | 7 | 51 | 2 | 23870127 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 4.41e-05 | 440 | 51 | 6 | 34244565 | |
| Pubmed | 4.60e-05 | 268 | 51 | 5 | 33640491 | ||
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 4.64e-05 | 444 | 51 | 6 | 34795231 | |
| Pubmed | 4.82e-05 | 660 | 51 | 7 | 32780723 | ||
| Pubmed | 4.93e-05 | 449 | 51 | 6 | 31732153 | ||
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | 5.70e-05 | 678 | 51 | 7 | 30209976 | |
| Pubmed | Gene expression in the developing mouse retina by EST sequencing and microarray analysis. | 5.73e-05 | 142 | 51 | 4 | 11812828 | |
| Pubmed | 5.87e-05 | 8 | 51 | 2 | 25078495 | ||
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | 6.66e-05 | 695 | 51 | 7 | 23602568 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | 6.89e-05 | 477 | 51 | 6 | 31300519 | |
| Pubmed | 7.41e-05 | 707 | 51 | 7 | 19738201 | ||
| Pubmed | SEL1L nucleates a protein complex required for dislocation of misfolded glycoproteins. | 7.54e-05 | 9 | 51 | 2 | 18711132 | |
| Pubmed | 7.54e-05 | 9 | 51 | 2 | 11956313 | ||
| Pubmed | 7.54e-05 | 9 | 51 | 2 | 8838651 | ||
| Pubmed | 7.81e-05 | 488 | 51 | 6 | 31324722 | ||
| Pubmed | 7.86e-05 | 154 | 51 | 4 | 36490346 | ||
| Pubmed | 8.22e-05 | 57 | 51 | 3 | 21555454 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 8.63e-05 | 497 | 51 | 6 | 36774506 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | 8.73e-05 | 498 | 51 | 6 | 36634849 | |
| Pubmed | 9.13e-05 | 731 | 51 | 7 | 29298432 | ||
| Pubmed | 9.22e-05 | 503 | 51 | 6 | 16964243 | ||
| Pubmed | TRAF3IP1 AKAP17A SPTBN2 DYNC2I1 AFDN USP54 SNRNP70 ANKRD6 ST13 | 9.36e-05 | 1285 | 51 | 9 | 35914814 | |
| Pubmed | 1.06e-04 | 1014 | 51 | 8 | 32416067 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 1.15e-04 | 759 | 51 | 7 | 35915203 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | ZNF609 TRAF3IP1 GKAP1 DYNC2I1 AFDN CSPP1 PHLDB2 RSRC1 CLASRP | 1.15e-04 | 1321 | 51 | 9 | 27173435 |
| Pubmed | 1.22e-04 | 65 | 51 | 3 | 32120844 | ||
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | 1.23e-04 | 330 | 51 | 5 | 33301849 | |
| Pubmed | 1.26e-04 | 332 | 51 | 5 | 25693804 | ||
| Pubmed | 1.33e-04 | 538 | 51 | 6 | 28524877 | ||
| Pubmed | 1.34e-04 | 177 | 51 | 4 | 26206133 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | 1.38e-04 | 1353 | 51 | 9 | 29467282 | |
| Pubmed | Regulation of epidermal differentiation through KDF1-mediated deubiquitination of IKKα. | 1.50e-04 | 182 | 51 | 4 | 32239614 | |
| Pubmed | Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration. | 1.62e-04 | 558 | 51 | 6 | 35063084 | |
| Pubmed | 1.63e-04 | 13 | 51 | 2 | 18796539 | ||
| Pubmed | 1.65e-04 | 560 | 51 | 6 | 35241646 | ||
| Pubmed | 1.71e-04 | 809 | 51 | 7 | 32129710 | ||
| Pubmed | 1.78e-04 | 568 | 51 | 6 | 37774976 | ||
| Pubmed | Human BRE1 is an E3 ubiquitin ligase for Ebp1 tumor suppressor. | 1.90e-04 | 14 | 51 | 2 | 19037095 | |
| Pubmed | 2.10e-04 | 1431 | 51 | 9 | 37142655 | ||
| Pubmed | 2.23e-04 | 1442 | 51 | 9 | 35575683 | ||
| Interaction | SMC5 interactions | DHX15 CWF19L2 ZNF609 RBM25 CALD1 INCENP BCORL1 NUMA1 KRI1 AFDN LRRC59 SREK1 DBN1 SNRNP70 EPB41 | 1.46e-08 | 1000 | 51 | 15 | int:SMC5 |
| Interaction | SRRM4 interactions | 3.48e-08 | 37 | 51 | 5 | int:SRRM4 | |
| Interaction | ZCCHC10 interactions | 1.30e-07 | 236 | 51 | 8 | int:ZCCHC10 | |
| Interaction | SNRNP40 interactions | CWF19L2 ZNF609 RBM25 AKAP17A NUMA1 KRI1 SREK1 SNRNP70 SPTY2D1 RSRC1 CLASRP | 4.35e-07 | 637 | 51 | 11 | int:SNRNP40 |
| Interaction | MARCKS interactions | 2.19e-06 | 601 | 51 | 10 | int:MARCKS | |
| Interaction | YAP1 interactions | DHX15 RBM25 GNA14 CALD1 SYTL4 SPTBN2 NUMA1 SMARCA2 AFDN LRRC59 DBN1 SNRNP70 EPB41 | 2.31e-06 | 1095 | 51 | 13 | int:YAP1 |
| Interaction | SRRM1 interactions | 2.43e-06 | 348 | 51 | 8 | int:SRRM1 | |
| Interaction | DDX23 interactions | CWF19L2 RBM25 AKAP17A KRI1 LRRC59 SREK1 SNRNP70 RSRC1 CLASRP | 2.86e-06 | 480 | 51 | 9 | int:DDX23 |
| Interaction | ASF1A interactions | 2.94e-06 | 249 | 51 | 7 | int:ASF1A | |
| Interaction | KIF20A interactions | DHX15 RBM25 FAF2 GNA14 INCENP SPTBN2 NUMA1 SMARCA2 USP54 DBN1 SNRNP70 PHLDB2 | 9.21e-06 | 1052 | 51 | 12 | int:KIF20A |
| Interaction | CIT interactions | DHX15 RBM25 FAF2 INCENP SPTBN2 NUMA1 SMARCA2 KRI1 LRRC59 CTIF SREK1 DBN1 SNRNP70 CSPP1 | 9.64e-06 | 1450 | 51 | 14 | int:CIT |
| Interaction | ECT2 interactions | DHX15 CWF19L2 INCENP SPTBN2 NUMA1 GKAP1 KRI1 SREK1 DBN1 SNRNP70 PHLDB2 | 1.07e-05 | 887 | 51 | 11 | int:ECT2 |
| Interaction | JMJD6 interactions | 1.27e-05 | 205 | 51 | 6 | int:JMJD6 | |
| Interaction | SIRT7 interactions | DHX15 RBM25 INCENP SPTBN2 NUMA1 SMARCA2 KRI1 AFDN ASCC3 SNRNP70 | 1.43e-05 | 744 | 51 | 10 | int:SIRT7 |
| Interaction | FLOT1 interactions | 2.35e-05 | 475 | 51 | 8 | int:FLOT1 | |
| Interaction | NR2C2 interactions | DHX15 RBM25 AKAP17A NUMA1 SMARCA2 KRI1 AFDN LRRC59 SREK1 ASCC3 SNRNP70 ST13 RSRC1 | 3.35e-05 | 1403 | 51 | 13 | int:NR2C2 |
| Interaction | KIF23 interactions | DHX15 RBM25 FAF2 AKAP17A INCENP KRI1 LRRC59 DBN1 SNRNP70 SPTY2D1 PHLDB2 | 4.30e-05 | 1031 | 51 | 11 | int:KIF23 |
| Interaction | CHMP4C interactions | 4.98e-05 | 687 | 51 | 9 | int:CHMP4C | |
| Interaction | LGR4 interactions | 5.03e-05 | 262 | 51 | 6 | int:LGR4 | |
| Interaction | CALD1 interactions | 5.36e-05 | 265 | 51 | 6 | int:CALD1 | |
| Interaction | ACTC1 interactions | 5.38e-05 | 694 | 51 | 9 | int:ACTC1 | |
| Interaction | MYO1C interactions | 5.99e-05 | 397 | 51 | 7 | int:MYO1C | |
| Interaction | MECP2 interactions | DHX15 CWF19L2 RBM25 AKAP17A SPTBN2 CFAP45 SMARCA2 LRRC59 UPF3A SREK1 DBN1 SNRNP70 | 6.76e-05 | 1287 | 51 | 12 | int:MECP2 |
| Interaction | EGR2 interactions | 7.11e-05 | 171 | 51 | 5 | int:EGR2 | |
| Interaction | TAF15 interactions | 7.11e-05 | 408 | 51 | 7 | int:TAF15 | |
| Interaction | OBSL1 interactions | DHX15 RBM25 CALD1 SPTBN2 NUMA1 CFAP45 AFDN LRRC59 SNRNP70 PHLDB2 | 7.37e-05 | 902 | 51 | 10 | int:OBSL1 |
| Interaction | SNIP1 interactions | 8.15e-05 | 417 | 51 | 7 | int:SNIP1 | |
| Interaction | CFAP20 interactions | 8.26e-05 | 91 | 51 | 4 | int:CFAP20 | |
| Interaction | SRSF1 interactions | 8.50e-05 | 570 | 51 | 8 | int:SRSF1 | |
| Interaction | SPTBN1 interactions | 8.65e-05 | 421 | 51 | 7 | int:SPTBN1 | |
| Interaction | WWTR1 interactions | 8.78e-05 | 422 | 51 | 7 | int:WWTR1 | |
| Interaction | BIRC3 interactions | DHX15 RBM25 FAF2 INCENP NUMA1 RNF20 KRI1 AFDN LRRC59 DBN1 SNRNP70 ST13 | 9.54e-05 | 1334 | 51 | 12 | int:BIRC3 |
| Interaction | DISC1 interactions | 9.73e-05 | 429 | 51 | 7 | int:DISC1 | |
| Interaction | CAPZA2 interactions | 9.87e-05 | 430 | 51 | 7 | int:CAPZA2 | |
| Interaction | ARF6 interactions | 1.01e-04 | 584 | 51 | 8 | int:ARF6 | |
| Interaction | FMNL2 interactions | 1.03e-04 | 185 | 51 | 5 | int:FMNL2 | |
| Interaction | SP7 interactions | 1.14e-04 | 304 | 51 | 6 | int:SP7 | |
| Interaction | SAP18 interactions | 1.16e-04 | 305 | 51 | 6 | int:SAP18 | |
| Interaction | SRPK3 interactions | 1.17e-04 | 190 | 51 | 5 | int:SRPK3 | |
| Interaction | SUPT16H interactions | 1.17e-04 | 442 | 51 | 7 | int:SUPT16H | |
| Interaction | MYO5B interactions | 1.34e-04 | 103 | 51 | 4 | int:MYO5B | |
| Interaction | KMT2A interactions | 1.36e-04 | 314 | 51 | 6 | int:KMT2A | |
| Interaction | AUTS2 interactions | 1.41e-04 | 40 | 51 | 3 | int:AUTS2 | |
| Interaction | SNRNP70 interactions | DHX15 RBM25 SPTBN2 KRI1 LRRC59 SREK1 DBN1 SNRNP70 RSRC1 CLASRP | 1.51e-04 | 984 | 51 | 10 | int:SNRNP70 |
| Interaction | ABCF1 interactions | 1.52e-04 | 201 | 51 | 5 | int:ABCF1 | |
| Interaction | BARD1 interactions | 1.59e-04 | 323 | 51 | 6 | int:BARD1 | |
| Interaction | AR interactions | DHX15 ZNF609 RBM25 FAF2 INTS13 NUMA1 RNF20 SMARCA2 RERE USP54 | 1.62e-04 | 992 | 51 | 10 | int:AR |
| Interaction | RSL1D1 interactions | 1.92e-04 | 479 | 51 | 7 | int:RSL1D1 | |
| Interaction | TDRD3 interactions | 1.95e-04 | 212 | 51 | 5 | int:TDRD3 | |
| Interaction | MEN1 interactions | 2.18e-04 | 1029 | 51 | 10 | int:MEN1 | |
| Interaction | ARL14 interactions | 2.33e-04 | 119 | 51 | 4 | int:ARL14 | |
| Interaction | YWHAG interactions | DHX15 LSR AKAP17A GRK5 AFDN USP54 CSPP1 ST13 EPB41 PHLDB2 RSRC1 | 2.36e-04 | 1248 | 51 | 11 | int:YWHAG |
| Interaction | ITPRID2 interactions | 2.41e-04 | 120 | 51 | 4 | int:ITPRID2 | |
| Interaction | ERG interactions | 2.46e-04 | 223 | 51 | 5 | int:ERG | |
| Interaction | NCBP1 interactions | 2.56e-04 | 353 | 51 | 6 | int:NCBP1 | |
| Interaction | FOXC1 interactions | 2.73e-04 | 228 | 51 | 5 | int:FOXC1 | |
| Interaction | KCNA3 interactions | 3.00e-04 | 871 | 51 | 9 | int:KCNA3 | |
| Interaction | ZC3H18 interactions | 3.15e-04 | 877 | 51 | 9 | int:ZC3H18 | |
| Interaction | RNF113A interactions | 3.20e-04 | 692 | 51 | 8 | int:RNF113A | |
| Interaction | CXADR interactions | 3.25e-04 | 369 | 51 | 6 | int:CXADR | |
| Interaction | IFI6 interactions | 3.46e-04 | 54 | 51 | 3 | int:IFI6 | |
| Interaction | NKAP interactions | 3.46e-04 | 132 | 51 | 4 | int:NKAP | |
| Interaction | TMOD3 interactions | 3.66e-04 | 243 | 51 | 5 | int:TMOD3 | |
| Interaction | UBR5 interactions | 3.68e-04 | 533 | 51 | 7 | int:UBR5 | |
| Interaction | ST13P5 interactions | 4.08e-04 | 12 | 51 | 2 | int:ST13P5 | |
| Interaction | CHEK2 interactions | 4.16e-04 | 250 | 51 | 5 | int:CHEK2 | |
| Interaction | RB1CC1 interactions | 4.19e-04 | 387 | 51 | 6 | int:RB1CC1 | |
| Interaction | MAPT interactions | UBXN4 FAF2 SPTBN2 SMARCA2 AFDN PKN1 LRRC59 DBN1 SNRNP70 EPB41 | 4.25e-04 | 1119 | 51 | 10 | int:MAPT |
| Interaction | DCAF15 interactions | 4.56e-04 | 255 | 51 | 5 | int:DCAF15 | |
| Interaction | DCPS interactions | 4.60e-04 | 394 | 51 | 6 | int:DCPS | |
| Interaction | PAIP1 interactions | 5.07e-04 | 146 | 51 | 4 | int:PAIP1 | |
| Interaction | CEP70 interactions | 5.15e-04 | 262 | 51 | 5 | int:CEP70 | |
| Interaction | CCNT2 interactions | 5.20e-04 | 62 | 51 | 3 | int:CCNT2 | |
| Interaction | RPS10 interactions | 5.32e-04 | 567 | 51 | 7 | int:RPS10 | |
| Interaction | ERGIC1 interactions | 5.33e-04 | 264 | 51 | 5 | int:ERGIC1 | |
| Interaction | NOP56 interactions | 5.49e-04 | 570 | 51 | 7 | int:NOP56 | |
| Interaction | RHOD interactions | 5.61e-04 | 572 | 51 | 7 | int:RHOD | |
| Interaction | GATA4 interactions | 5.75e-04 | 411 | 51 | 6 | int:GATA4 | |
| Interaction | CHD3 interactions | 5.81e-04 | 757 | 51 | 8 | int:CHD3 | |
| Interaction | CGN interactions | 5.90e-04 | 152 | 51 | 4 | int:CGN | |
| Interaction | CSNK2A1 interactions | 5.91e-04 | 956 | 51 | 9 | int:CSNK2A1 | |
| Interaction | IFI27L1 interactions | 5.97e-04 | 65 | 51 | 3 | int:IFI27L1 | |
| Interaction | CDH1 interactions | 6.39e-04 | 768 | 51 | 8 | int:CDH1 | |
| Interaction | H3C14 interactions | 6.51e-04 | 156 | 51 | 4 | int:H3C14 | |
| Interaction | SLBP interactions | 6.53e-04 | 67 | 51 | 3 | int:SLBP | |
| Interaction | NUDCD2 interactions | 6.77e-04 | 424 | 51 | 6 | int:NUDCD2 | |
| Interaction | RNPS1 interactions | 6.85e-04 | 425 | 51 | 6 | int:RNPS1 | |
| Interaction | ENTPD1 interactions | 7.37e-04 | 16 | 51 | 2 | int:ENTPD1 | |
| Interaction | CSDE1 interactions | 7.42e-04 | 284 | 51 | 5 | int:CSDE1 | |
| Interaction | HDAC5 interactions | 7.46e-04 | 432 | 51 | 6 | int:HDAC5 | |
| Interaction | CFAP184 interactions | 7.49e-04 | 162 | 51 | 4 | int:CFAP184 | |
| Interaction | RBBP5 interactions | 7.78e-04 | 287 | 51 | 5 | int:RBBP5 | |
| Interaction | DST interactions | 7.78e-04 | 287 | 51 | 5 | int:DST | |
| Interaction | SGF29 interactions | 7.84e-04 | 164 | 51 | 4 | int:SGF29 | |
| Interaction | INF2 interactions | 7.90e-04 | 288 | 51 | 5 | int:INF2 | |
| Interaction | SSX2IP interactions | 7.90e-04 | 288 | 51 | 5 | int:SSX2IP | |
| Interaction | TLX3 interactions | 8.28e-04 | 291 | 51 | 5 | int:TLX3 | |
| Interaction | DHX8 interactions | 8.40e-04 | 292 | 51 | 5 | int:DHX8 | |
| Interaction | CAPRIN1 interactions | 9.33e-04 | 451 | 51 | 6 | int:CAPRIN1 | |
| Interaction | SNRPA1 interactions | 9.48e-04 | 300 | 51 | 5 | int:SNRPA1 | |
| Cytoband | 3q13.2 | 5.51e-04 | 31 | 51 | 2 | 3q13.2 | |
| GeneFamily | UBX domain containing | 1.92e-04 | 13 | 29 | 2 | 364 | |
| GeneFamily | RNA binding motif containing | 4.70e-03 | 213 | 29 | 3 | 725 | |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | 1.05e-08 | 221 | 51 | 8 | M39222 | |
| Coexpression | DESCARTES_FETAL_STOMACH_CILIATED_EPITHELIAL_CELLS | 1.70e-07 | 317 | 51 | 8 | M40298 | |
| Coexpression | GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH2_UP | 2.48e-06 | 200 | 51 | 6 | M4528 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | 4.34e-06 | 656 | 51 | 9 | M18979 | |
| Coexpression | DESCARTES_MAIN_FETAL_CILIATED_EPITHELIAL_CELLS | LRRIQ1 TRAF3IP1 CFAP45 DYNC2I1 STMND1 CCDC181 CFAP44 CSPP1 HYDIN | 5.67e-06 | 678 | 51 | 9 | M40124 |
| Coexpression | TRAVAGLINI_LUNG_CILIATED_CELL | LRRIQ1 GNA14 TRAF3IP1 CCDC82 CFAP45 DYNC2I1 STMND1 CCDC181 CFAP44 CSPP1 HYDIN | 6.48e-06 | 1093 | 51 | 11 | M41649 |
| Coexpression | DESCARTES_FETAL_LUNG_CILIATED_EPITHELIAL_CELLS | 9.00e-06 | 540 | 51 | 8 | M40241 | |
| Coexpression | RATTENBACHER_BOUND_BY_CELF1 | 2.32e-05 | 444 | 51 | 7 | M2505 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | 3.20e-05 | 467 | 51 | 7 | M1347 | |
| Coexpression | GSE29617_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_2008_UP | 3.95e-05 | 196 | 51 | 5 | M4928 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | 4.02e-05 | 484 | 51 | 7 | MM999 | |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | 6.24e-05 | 519 | 51 | 7 | M3395 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL1 | 7.32e-05 | 364 | 51 | 6 | M39057 | |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | 8.28e-05 | 543 | 51 | 7 | MM997 | |
| Coexpression | HEVNER_CORTEX_APICAL_AND_BASAL_INTERMEDIATE_PROGENITOR_CELLS | 1.70e-04 | 55 | 51 | 3 | MM397 | |
| Coexpression | GAO_ESOPHAGUS_25W_C1_CILIATED_EPITHELIAL_CELLS | 2.58e-04 | 459 | 51 | 6 | M39136 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 4.55e-05 | 271 | 51 | 6 | Facebase_RNAseq_e10.5_Mandibular Arch_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 8.28e-05 | 186 | 51 | 5 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| ToppCell | Epithelial-Epithelial-D_(Ciliated)|Epithelial / shred on cell class and cell subclass (v4) | 4.37e-11 | 188 | 51 | 8 | 8f30535a32968a81a304315a49c0d90a77d36948 | |
| ToppCell | Epithelial-D_(Ciliated)|World / shred on cell class and cell subclass (v4) | 4.56e-11 | 189 | 51 | 8 | 0bf560b595c7a8450a46bc821b742b67965bd9f9 | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.96e-11 | 191 | 51 | 8 | bda8faf92495c8b362850c0aff4fc6fbdd9c563b | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.96e-11 | 191 | 51 | 8 | 6880fb348bb0915db9a5da4f3566ca9ff93ed258 | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.17e-11 | 192 | 51 | 8 | b5cdc2dae3154b1e4ade88f841f38584402ffe33 | |
| ToppCell | PND03-Epithelial-Epithelial_Airway|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.17e-11 | 192 | 51 | 8 | 2d8d5a38e205339eda9c8aca1ca9ba3dcbe5ae56 | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.62e-11 | 194 | 51 | 8 | 7a7ddccfe72a4a0dc4d1a5c809988f0069f9f1a3 | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_1|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.62e-11 | 194 | 51 | 8 | b4ce60c06568123008b1081d644733cb91c28f51 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.85e-11 | 195 | 51 | 8 | 649fd2336e963f6a150d182a53ad5dd838ca80b1 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.85e-11 | 195 | 51 | 8 | d211a836cf711fdb91b10d512f09d462be937cc5 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.85e-11 | 195 | 51 | 8 | 129ad5f4253ecb1a8477cc38773e6e91ea9570b0 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.85e-11 | 195 | 51 | 8 | 3e70ee987d66d450062d5df3d7c733ccc7344470 | |
| ToppCell | P03-Epithelial-airway_epithelial_cell-club_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.51e-09 | 181 | 51 | 7 | 60a91587c59029a34e7bec1255083337fe21b72a | |
| ToppCell | Ciliated_cells-B-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 1.57e-09 | 182 | 51 | 7 | e93968f800bfeb258e4e834fc8bf92d1cb72cd73 | |
| ToppCell | PND14-Epithelial-Epithelial_Airway|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.90e-09 | 187 | 51 | 7 | 1399c703505211c510b3f14c7a2aa9930566c473 | |
| ToppCell | PND28-Epithelial-Epithelial_Airway|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.90e-09 | 187 | 51 | 7 | f777dd5eb5ccd554ebe1ed60a738b5dd45e18bb9 | |
| ToppCell | 21-Trachea-Epithelial-Intermediate_ciliated|Trachea / Age, Tissue, Lineage and Cell class | 1.90e-09 | 187 | 51 | 7 | 1a2178a195d078d1963947b327c6d0d4f2f48341 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.04e-09 | 189 | 51 | 7 | 02c6128a9ab5818e0881dcadafdad5f08b9a67cf | |
| ToppCell | PND28-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.04e-09 | 189 | 51 | 7 | fa1ff8b7fa53f3148d9117d6e598097f03af5eb2 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.04e-09 | 189 | 51 | 7 | 164ea92ff6a1aa2ead1c9b8f64f99a9d65437232 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.04e-09 | 189 | 51 | 7 | 407d8a59969d83f014600aae1a55092283a13970 | |
| ToppCell | PND28-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.04e-09 | 189 | 51 | 7 | 565063f9e3dd79164321f8a394bd12c176baf202 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.04e-09 | 189 | 51 | 7 | a85099bd598a27ee64ee0664d051d89fa8d62fc9 | |
| ToppCell | PND28-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.04e-09 | 189 | 51 | 7 | 497be236848ebf5ad75d1f0c71e6261f5d3521da | |
| ToppCell | PND14-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.12e-09 | 190 | 51 | 7 | 35248a8be476ea8d06d67c3d98a25be1f7c150b7 | |
| ToppCell | PND14-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.12e-09 | 190 | 51 | 7 | 5f5206f9e725070d865f4c891ff08bb750e58582 | |
| ToppCell | PND14-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.12e-09 | 190 | 51 | 7 | 088e3f39a1e5e11354d6e7458e8e6a39f14936b3 | |
| ToppCell | 15-Trachea-Epithelial-Intermediate_ciliated|Trachea / Age, Tissue, Lineage and Cell class | 2.28e-09 | 192 | 51 | 7 | 9cbe961a800c981cdc742a47ed18e9c8eb6430bd | |
| ToppCell | NS-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.54e-09 | 195 | 51 | 7 | 34e37cff4849696ca4ba5dd8fd2cf98fed8bc912 | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|Epithelial / Condition, Lineage and Cell class | 2.63e-09 | 196 | 51 | 7 | de7aa31354b019d7321a8ef965d59ce2e8b89276 | |
| ToppCell | critical-Epithelial-Ciliated|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.63e-09 | 196 | 51 | 7 | 27b855c6e1ae44f16db998cf0e81bd686b9cee7e | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 2.73e-09 | 197 | 51 | 7 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | facs-Trachea-nan-18m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.12e-08 | 176 | 51 | 6 | ed788a5969edfd1199828ca5b0dd34e7f29c4d30 | |
| ToppCell | facs-Trachea-18m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell-ciliated_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.66e-08 | 179 | 51 | 6 | d4efbc34f52136039b96451fd0b0a0ad164197c6 | |
| ToppCell | facs-Trachea-18m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.66e-08 | 179 | 51 | 6 | 8a66d197a2f55d763ff7ef0bec89ee96f59c3937 | |
| ToppCell | P03-Epithelial-airway_epithelial_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.05e-08 | 181 | 51 | 6 | 1ea21d860d4d7abab3e21e130a16d044006656ee | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.66e-08 | 184 | 51 | 6 | 797b6a6d6f6aafae98f75ca8bffe8263f8d3ff9b | |
| ToppCell | P07-Epithelial-airway_epithelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.66e-08 | 184 | 51 | 6 | a5e7af3392e9d6ddad0397f1eeb6b91ed1107cc2 | |
| ToppCell | P07-Epithelial-airway_epithelial_cell-club_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.66e-08 | 184 | 51 | 6 | ab469b9e06212462cbe2e4db8775c6778db855e6 | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.66e-08 | 184 | 51 | 6 | 77d5b60a20b277f589b18f7a131142a7ef2dac17 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.10e-08 | 186 | 51 | 6 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | tumor_Lung-Epithelial_cells-tS3|Epithelial_cells / Location, Cell class and cell subclass | 7.33e-08 | 187 | 51 | 6 | 3cea677279e71fdb9879530dea10a5e6393beacd | |
| ToppCell | Ciliated_cells-B-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 7.33e-08 | 187 | 51 | 6 | 6fa38dbccca36bc7a4fef46de74c6688f599f421 | |
| ToppCell | Ciliated|World / Class top | 7.57e-08 | 188 | 51 | 6 | cc9178361360b5800f96516ed6a65089c144b1ce | |
| ToppCell | PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.81e-08 | 189 | 51 | 6 | b55de812043b670cbde810d7d42f45909b6d66ef | |
| ToppCell | PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.81e-08 | 189 | 51 | 6 | 4e83e49d1265ffe507fdb72924c77c4d1c73f0bd | |
| ToppCell | PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.31e-08 | 191 | 51 | 6 | 96483adb97c81208aa513782550acd8a08b63866 | |
| ToppCell | Ciliated-cil-3|World / Class top | 8.57e-08 | 192 | 51 | 6 | 4989ebb8812b8af1870599acd932849122c05a29 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 8.57e-08 | 192 | 51 | 6 | be592e661367affced9ebe80849b466e6adb3a34 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.57e-08 | 192 | 51 | 6 | 1b6cac8156e608061e1405e36e18d185b6fa8f6f | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 8.84e-08 | 193 | 51 | 6 | 0b62a6ddd7c42efd9f39781971d1438501e1fa8d | |
| ToppCell | ASK452-Epithelial-Ciliated|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 8.84e-08 | 193 | 51 | 6 | c0d10075862ac878aa05fc49c8b73e470783bf16 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.11e-08 | 194 | 51 | 6 | 3cd90d01ed5a5ce65aad8284dab2537ec16e3d7c | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.11e-08 | 194 | 51 | 6 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.11e-08 | 194 | 51 | 6 | a46238514bca920c3e3713d23c18ba24a09e2a29 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.40e-08 | 195 | 51 | 6 | 93b1559382a12cfb158aa5fac7386e38b4f87989 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.40e-08 | 195 | 51 | 6 | db4270c135c392ed443670981656e3cd5b95939d | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.40e-08 | 195 | 51 | 6 | 0e763f36786515698b593e5c93f6a56619c1242d | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.40e-08 | 195 | 51 | 6 | 6365e3893e38231090ec2dbef010dec71dea3d07 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.40e-08 | 195 | 51 | 6 | 9651ee03738226ee10e901f8b9ec6a417eb9c301 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.40e-08 | 195 | 51 | 6 | 581b04220587e1d5198b1abd6965965ace7803e7 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.68e-08 | 196 | 51 | 6 | 1386003f5d885f0ea080934f7e05fe05f142a3d5 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.98e-08 | 197 | 51 | 6 | 87db09f341e2b20eb6e1c3e917cb5c960387b3e9 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.98e-08 | 197 | 51 | 6 | 91637bdeab85024b5a02d1066f76cb803a2d6420 | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.98e-08 | 197 | 51 | 6 | 71fea4aa6ce96c7693fa94792d08770622873850 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.98e-08 | 197 | 51 | 6 | 22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.98e-08 | 197 | 51 | 6 | 3bbf068d2ad8196fbc85d3f311a7c54c9aece856 | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Ciliated|LPS_only / Treatment groups by lineage, cell group, cell type | 1.03e-07 | 198 | 51 | 6 | 6d90b541fde357fbb40f8f7d4e8628a48b679718 | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.03e-07 | 198 | 51 | 6 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | proximal-Epithelial-Ciliated|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.06e-07 | 199 | 51 | 6 | 9700f06e51ddca85e482b4f9bd4a79bfcd3cfb76 | |
| ToppCell | medial-Epithelial-Ciliated-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.06e-07 | 199 | 51 | 6 | 526002f16bbf61cf086278d45a401cc0b0b757a8 | |
| ToppCell | proximal-3-Epithelial-Ciliated|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.06e-07 | 199 | 51 | 6 | 1188afad6fd5f01f9aeba225f611f38b237dd2c9 | |
| ToppCell | medial-Epithelial-Ciliated|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.06e-07 | 199 | 51 | 6 | a2daa42b100c422dc8c04fb7d2ebf54293eef574 | |
| ToppCell | proximal-Epithelial-Ciliated-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.06e-07 | 199 | 51 | 6 | 2e8ace105c4e2405baa06d953e52888b54e2d055 | |
| ToppCell | medial-2-Epithelial-Ciliated|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.06e-07 | 199 | 51 | 6 | c02f04a5aa79ee0cf427f6e94b93ceab38ebbcd7 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Ciliated|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.09e-07 | 200 | 51 | 6 | 6a2ccc71a0cbe04a542c379b28b5006de53981c3 | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_ciliated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.09e-07 | 200 | 51 | 6 | 7cb3e3bd9e851ccb096e0a3471819471d85ebace | |
| ToppCell | (09)_Interm._secr.>cil.|World / shred by cell type by condition | 1.09e-07 | 200 | 51 | 6 | 3305e14dba12e94da42f0414fdc7a2c8caf0a183 | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_ciliated-Ciliated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.09e-07 | 200 | 51 | 6 | 8441e289377215a6877640946fe3f6de1f456502 | |
| ToppCell | lung-Ciliated_Epithelia|lung / shred on tissue and cell subclass | 1.36e-06 | 167 | 51 | 5 | 26cf1cfa58ee74794449a87eb19cd896e1ec8892 | |
| ToppCell | Ciliated_cells-A-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 1.36e-06 | 167 | 51 | 5 | edb722ee9b6ccd00fb038f702be8664020932659 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.40e-06 | 168 | 51 | 5 | 9a8709d34865cfa668d8f3335dc34fc86fc32482 | |
| ToppCell | Ciliated_cells-B-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 1.57e-06 | 172 | 51 | 5 | 187ae91148d293537afc77e10da2b64302322224 | |
| ToppCell | facs-Trachea-nan-24m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-06 | 173 | 51 | 5 | 27ae126c720f20d1fe116abbcd358e4cff8baf6b | |
| ToppCell | droplet-Lung-nan-21m-Epithelial-Ciliated_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-06 | 175 | 51 | 5 | 3ed22ea41810e73c02db4f2d03745e4ce7e43bb1 | |
| ToppCell | droplet-Lung-nan-21m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-06 | 175 | 51 | 5 | 8fb1e5f6aa68274adf322401db8c7b80e8c554d7 | |
| ToppCell | Ciliated_cells-B-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.81e-06 | 177 | 51 | 5 | c38138fb5ad9766c2d240811210c854338cd612e | |
| ToppCell | Ciliated_cells-A-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 1.86e-06 | 178 | 51 | 5 | 255473ee6df8a13079fb3bb61038162a40cb4c2c | |
| ToppCell | Ciliated_cells-A-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.91e-06 | 179 | 51 | 5 | 0e6c22de2e3fb0ff23b3301863cf4011c5c59dff | |
| ToppCell | ASK454-Epithelial-Ciliated|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.91e-06 | 179 | 51 | 5 | f21919ef9d3d984e2925ef3d24f89e20fe265dcd | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.96e-06 | 180 | 51 | 5 | 0c146e80d55d18b6988dd21b1da635801bd3140c | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.96e-06 | 180 | 51 | 5 | e9af22beae2f3c7fe213b4e19df84abfd2453433 | |
| ToppCell | Ciliated_cells-A-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 1.96e-06 | 180 | 51 | 5 | d9be152773fe9f2160edad9246fa03c03afeafd6 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.96e-06 | 180 | 51 | 5 | 11455ba704ac73f69b474845136cfecec6a88349 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.96e-06 | 180 | 51 | 5 | 1f1af4474f3f0ac3c0d6b1a6c875c354d36d8eec | |
| ToppCell | 368C-Epithelial_cells-Epithelial-F_(Ciliated)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.02e-06 | 181 | 51 | 5 | 5a4574f1bfd0b4ca78da7effda43420857e17296 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-F_(Ciliated)|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.02e-06 | 181 | 51 | 5 | a4e891603645f694687e68e585744ddc1a3c8697 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-06 | 182 | 51 | 5 | 587636c0f127231de21acd8aa632b74ff22ca8c2 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-06 | 182 | 51 | 5 | adfadd7893e74b3002f13f00875e3667d3493e0c | |
| ToppCell | 368C-Epithelial_cells-Epithelial-F_(Ciliated)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.07e-06 | 182 | 51 | 5 | f8c28fa76751062c4cfba0db8af1b377f947f739 | |
| Drug | Hexamethonium dibromide dihydrate [55-97-0]; Up 200; 10uM; MCF7; HT_HG-U133A | 2.64e-07 | 196 | 51 | 7 | 4965_UP | |
| Drug | Cefaclor [70356-03-5]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 4.92e-06 | 196 | 51 | 6 | 2843_DN | |
| Drug | Atropine-N-oxide hydrochloride [4574-60-1]; Down 200; 11.8uM; PC3; HT_HG-U133A | 5.06e-06 | 197 | 51 | 6 | 4476_DN | |
| Drug | Dehydrocholic acid [81-23-2]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 5.21e-06 | 198 | 51 | 6 | 5681_DN | |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A | 4.85e-05 | 178 | 51 | 5 | 3998_DN | |
| Drug | Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A | 4.98e-05 | 179 | 51 | 5 | 4585_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 6.13e-05 | 187 | 51 | 5 | 4302_DN | |
| Drug | Neostigmine bromide [114-80-7]; Down 200; 13.2uM; PC3; HT_HG-U133A | 6.28e-05 | 188 | 51 | 5 | 6735_DN | |
| Drug | Flupentixol dihydrochloride cis-(Z) [2413-38-9]; Down 200; 7.8uM; HL60; HT_HG-U133A | 6.44e-05 | 189 | 51 | 5 | 1288_DN | |
| Drug | Pyrimethamine [58-14-0]; Down 200; 16uM; HL60; HG-U133A | 6.61e-05 | 190 | 51 | 5 | 1974_DN | |
| Drug | Quercetine dihydrate [6151-25-3]; Down 200; 11.8uM; PC3; HT_HG-U133A | 7.29e-05 | 194 | 51 | 5 | 4264_DN | |
| Drug | Calycanthine [595-05-1]; Down 200; 11.6uM; PC3; HT_HG-U133A | 7.47e-05 | 195 | 51 | 5 | 5744_DN | |
| Drug | ST021200; Up 200; 10uM; PC3; HT_HG-U133A | 7.47e-05 | 195 | 51 | 5 | 7559_UP | |
| Drug | Lisinopril [83915-83-7]; Up 200; 9uM; MCF7; HT_HG-U133A | 7.47e-05 | 195 | 51 | 5 | 7403_UP | |
| Drug | Flucloxacillin sodium [1847-24-1]; Down 200; 8.4uM; PC3; HT_HG-U133A | 7.65e-05 | 196 | 51 | 5 | 5102_DN | |
| Drug | Fluvoxamine maleate [61718-82-9]; Down 200; 9.2uM; PC3; HT_HG-U133A | 7.84e-05 | 197 | 51 | 5 | 3995_DN | |
| Drug | Cefoxitin sodium salt [33564-30-6]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 7.84e-05 | 197 | 51 | 5 | 6796_UP | |
| Drug | Meclofenoxate hydrochloride [3685-84-5]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 7.84e-05 | 197 | 51 | 5 | 4729_UP | |
| Drug | Metyrapone [54-36-4]; Down 200; 17.6uM; PC3; HT_HG-U133A | 7.84e-05 | 197 | 51 | 5 | 4606_DN | |
| Drug | Alfuzosin hydrochloride [81403-68-1]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 7.84e-05 | 197 | 51 | 5 | 5605_UP | |
| Drug | Bucladesine sodium salt [16980-89-5]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 8.03e-05 | 198 | 51 | 5 | 3483_DN | |
| Drug | Isoxicam [34552-84-6]; Down 200; 12uM; MCF7; HT_HG-U133A | 8.03e-05 | 198 | 51 | 5 | 7028_DN | |
| Drug | (+) -Levobunolol hydrochloride [47141-41-3]; Down 200; 12.2uM; HL60; HT_HG-U133A | 8.03e-05 | 198 | 51 | 5 | 3016_DN | |
| Drug | Methacycline hydrochloride [3963-95-9]; Down 200; 8.4uM; PC3; HT_HG-U133A | 8.03e-05 | 198 | 51 | 5 | 4062_DN | |
| Drug | Tubocurarine chloride pentahydrate (+) [6989-98-6]; Up 200; 5.2uM; PC3; HT_HG-U133A | 8.03e-05 | 198 | 51 | 5 | 6351_UP | |
| Drug | Buflomedil hydrochloride [35543-24-9]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 8.22e-05 | 199 | 51 | 5 | 4840_UP | |
| Drug | Ebselen [60940-34-3]; Down 200; 14.6uM; HL60; HT_HG-U133A | 8.22e-05 | 199 | 51 | 5 | 2717_DN | |
| Drug | Khellin [82-02-0]; Up 200; 15.4uM; PC3; HT_HG-U133A | 8.22e-05 | 199 | 51 | 5 | 6641_UP | |
| Drug | Lincomycin hydrochloride [859-18-7]; Up 200; 9uM; MCF7; HT_HG-U133A | 8.22e-05 | 199 | 51 | 5 | 5992_UP | |
| Drug | Milrinone [78415-72-2]; Down 200; 19uM; MCF7; HT_HG-U133A | 8.42e-05 | 200 | 51 | 5 | 3552_DN | |
| Drug | 2-nitro-5-thiocyanobenzoic acid | 1.71e-04 | 48 | 51 | 3 | CID000092266 | |
| Disease | unipolar depression, bipolar disorder | 1.55e-04 | 156 | 51 | 4 | EFO_0003761, MONDO_0004985 | |
| Disease | Majewski Syndrome | 2.63e-04 | 14 | 51 | 2 | C0024507 | |
| Disease | Infiltrating duct carcinoma of female breast | 6.02e-04 | 21 | 51 | 2 | C3165106 | |
| Disease | revision of total joint arthroplasty | 1.08e-03 | 28 | 51 | 2 | EFO_0020974 | |
| Disease | Polydactyly | 1.10e-03 | 117 | 51 | 3 | C0152427 | |
| Disease | Parkinson's disease (biomarker_via_orthology) | 1.24e-03 | 30 | 51 | 2 | DOID:14330 (biomarker_via_orthology) | |
| Disease | facial morphology measurement | 1.24e-03 | 466 | 51 | 5 | EFO_0007841 | |
| Disease | blood pressure, chronic obstructive pulmonary disease | 1.41e-03 | 32 | 51 | 2 | EFO_0000341, EFO_0004325 | |
| Disease | mean arterial pressure | 1.68e-03 | 499 | 51 | 5 | EFO_0006340 | |
| Disease | childhood gender nonconformity | 2.53e-03 | 43 | 51 | 2 | EFO_0020103 | |
| Disease | neuroticism measurement, cognitive function measurement | 2.90e-03 | 566 | 51 | 5 | EFO_0007660, EFO_0008354 | |
| Disease | coffee consumption measurement | 3.87e-03 | 182 | 51 | 3 | EFO_0006781 | |
| Disease | unipolar depression | 4.50e-03 | 1206 | 51 | 7 | EFO_0003761 | |
| Disease | neuroticism measurement | 4.65e-03 | 909 | 51 | 6 | EFO_0007660 | |
| Disease | Parkinson's disease (is_marker_for) | 6.03e-03 | 67 | 51 | 2 | DOID:14330 (is_marker_for) | |
| Disease | depressive symptom measurement | 6.27e-03 | 426 | 51 | 4 | EFO_0007006 | |
| Disease | total blood protein measurement | 7.52e-03 | 449 | 51 | 4 | EFO_0004536 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KEKARLEEERERKRR | 1421 | P55196 | |
| EDLIRMRKKKRERLD | 641 | P11171 | |
| KEREREREREKEKER | 576 | Q5VTR2 | |
| SKDRLRRRLKEKDEV | 346 | O43310 | |
| EEEEGLLKRKKRRRQ | 1321 | Q5H9F3 | |
| KDGRIERLKLELERK | 251 | Q5VSY0 | |
| RGDREREREKEKEKE | 46 | O43143 | |
| KRERQRELKEKIREE | 691 | Q96MT7 | |
| GRSLRKKRERLKEER | 271 | Q9Y2G4 | |
| KREEREIKERIERVK | 241 | P50502 | |
| EREREREREREKDKK | 416 | P49756 | |
| REREREKDKKRDREE | 421 | P49756 | |
| EEEERKKRGRKREDK | 566 | Q9NVM9 | |
| GKEKERLRDRDRERD | 256 | Q8TDR0 | |
| EDKRRRLEEVKLKRE | 561 | Q9NQS7 | |
| RLEEVKLKREERLRK | 566 | Q9NQS7 | |
| ELRKREKAEEKERRR | 186 | Q96AG4 | |
| KLRRTRGEEKEAEKE | 286 | Q9C098 | |
| ERRRDAKDREKEKLK | 91 | Q8WVS4 | |
| REKEKDRRARKEELR | 121 | Q8WVS4 | |
| RERIDEIKRKKLEEL | 511 | Q9UL16 | |
| EKEERRKELKRLRGE | 41 | Q2TBE0 | |
| REREERRKKEREEKE | 641 | Q1MSJ5 | |
| ERRKEKREETRERKK | 326 | Q8N9T8 | |
| RERRLKSLEEELERK | 741 | Q96RT7 | |
| RKEEERKKALDERLR | 191 | Q16643 | |
| RKRLEEEQRIKEERK | 336 | Q96JM4 | |
| LEEKREKLKREEERR | 346 | Q5TID7 | |
| DLEEEDIKRGKRKRL | 171 | Q8N4S0 | |
| LEREKAERERLEKLR | 2526 | Q4G0P3 | |
| RGRKEKVKREEVDRR | 386 | P34947 | |
| LEEAVRKKGSEERRR | 591 | Q86X29 | |
| KRERKELEEERAGRK | 751 | Q14980 | |
| RRDKKDARRELKLLL | 26 | O95837 | |
| KEERRRSRERSKDKD | 271 | P08621 | |
| EEVRKADEKRIRRLK | 26 | Q96C24 | |
| EMEEEVRLKKRKRRR | 1336 | P51531 | |
| RRELEKKRLREEEKR | 241 | Q9H1J1 | |
| EEEKRRRREEERCKK | 251 | Q9H1J1 | |
| KREERERKRRKEEEV | 311 | Q96CS3 | |
| RLRREIRKELKLKEG | 41 | Q16512 | |
| KEKEKERERERERER | 1186 | Q9P2R6 | |
| KERVKEKDREKERER | 271 | Q8WXA9 | |
| KEREREKEREKEKER | 281 | Q8WXA9 | |
| EAKKRALEEEKRRRE | 1061 | Q86SQ0 | |
| KEEELRRKALEEKRR | 51 | Q68D10 | |
| RRKALEEKRRKEELV | 56 | Q68D10 | |
| ELERERKREEKLRKR | 311 | Q02040 | |
| ADRKLREEEEKRRLK | 591 | Q05682 | |
| RREEKRIARREKKAG | 341 | Q8N3C0 | |
| KIRMKERERREKERE | 621 | Q8N2M8 | |
| TALEEREKERKRKRE | 2076 | O15020 | |
| EERDRKLKEERSRSK | 1161 | O15014 | |
| RERRKGRDKEKREKE | 136 | Q96IZ7 | |
| AEERRKTKEEEIRKR | 176 | H3BQB6 | |
| KTKEEEIRKRLRSDR | 181 | H3BQB6 | |
| RLTKKLEERREEKRK | 201 | Q92575 | |
| ELRRKREKELEAAKG | 756 | Q70EL1 |